Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sevion Therapeutics Inc (OTCBB - OTCQB:SVON)

0.80
Delayed Data
As of 10:31am ET
 +0.0499 / +6.65%
Today’s Change
0.51
Today|||52-Week Range
1.77
-2.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$13.1M

Company Description

Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops, and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in Bridgewater, NJ.

Contact Information

Sevion Therapeutics, Inc.
721 Route 202/206
Bridgewater New Jersey 08807-1760
P:(908) 864-4444
Investor Relations:

Employees

Shareholders

Individual stakeholders17.63%
Mutual fund holders--
Other institutional--

Top Executives

David S. RectorPresident & Chief Executive Officer
James R. SchmidtChief Financial & Accounting Officer
James Joseph GrazianoChief Technology Officer
Vaughn V. SmiderDirector & Chief Scientific Officer
Miguel A. de los RíosVice President-Research & Development